PVD usually is a term used to
refer to atherosclerotic
blockages found in the lower extremity
PVD can result from atherosclerosis, inflammatory processes leading to stenosis, an embolism, or thrombus formation.
And can also refer
to peripheral artery disease (PAD) or peripheral artery occlusive disease (PAOD)
The prevalence of peripheral vascular disease in the general population is 12–14%
Peripheral vascular disease affects 1 in 3 diabetics over the age of 50.
Millions of
patients around the world suffer the debilitating effects of peripheral artery disease (PAD), including amputation and an elevated risk for major
cardiovascular events.
Nowadays: MAJESTIC Trial Undergoing To Study Self-Expanding DES System Designed To Treat Superficial Femoral Artery (SFA) Lesions
The MAJESTIC trial --
designed to evaluate the safety and performance of the first Boston Scientific peripheral
drug-eluting stent system -- is projected
to enroll 55 patients across 15 centers in Europe Australia and New
Zealand. The Innova DES System reflects more than a decade of Boston
Scientific experience in drug-eluting technologies.
 |
| Innova DES |
